Join the Oncology Voice Network. Join for Free
Professional Development: Why Consider an Executive Coach
Life Reset Labs Dana Paskalis coaching in professional development career coaching executive coach advice

Professional Development: Why Consider an Executive Coach


Share This Article


Summary

In this episode, Dana Paskalis, founder of Life Reset Labs, joins to discuss the pivotal role of coaching in personal and professional development. Dana outlines her career path leading to the creation of her coaching company and highlights the significance of self-talk and mindset in advancing one's career. She explores the differences between a mentor and a coach, offering advice on when to seek professional guidance. The conversation also covers the impact of company culture and handling layoffs, alongside strategies for proactive career planning. The episode concludes with a reminder to subscribe for more insights.

Today’s guest is Dana Paskalis, CEO and Founder of Life Reset Labs and we discuss why professionals should consider an executive or career coach
Dana discusses….

๐Ÿ‘‰ What led her to transition to a Certified Coach and Life Strategist
๐Ÿ‘‰ What exactly a Certified Coach and Life Strategist does
๐Ÿ‘‰ What is the difference between a coach and a mentor
๐Ÿ‘‰ Who should consider a coach (and who doesn’t need a coach)
๐Ÿ‘‰ Tips and career advice for MSLs
๐Ÿ‘‰ Tips and advice for finding success in 2023

Click for Source
Life Reset Labs, Dana Paskalis, coaching in professional development, career coaching, executive coach advice

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2
OVN Avatar Guillaume Beinse, MD, Virgile Tellier, Valentin Charvet, MSc, Eric Deutsch, MD, PhD, Isabelle Borget, PharmD, PhD, Christophe Massard, MD, PhD., Antoine Hollebecque, MD, PhD, and Loic Verlingue, MD

Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2

Article
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
OVN Avatar Laleh Amiri-Kordestani & Richard Pazdur

Oncology approvals in 2020: a year of firsts in the midst of a pandemic

Article
Real-World Evidence in Oncology: Opportunities and Limitations
OVN Avatar Massimo Di Maio, Francesco Perrone, Pierfranco Conte

Real-World Evidence in Oncology: Opportunities and Limitations

Article
Accelerated drug approvals in oncology: Pros and cons
OVN Avatar Thakur, Sayanta & Lahiry, Sandeep

Accelerated drug approvals in oncology: Pros and cons

Article
Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives
OVN Avatar Jaques van Heerden, MD, Mohamed Zaghloul, MD, Anouk Neven, MSc, Teresa de Rojas, MD, PhD, Jennifer Geel, MD, Catherine Patte, MD, Joyce Balagadde-Kambugu, MD, Peter Hesseling, MD, Francine Tchintseme, MD, Eric Bouffet, MD, and Laila Hessissen, MD

Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives

Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Explore OVN